One prominent hallmark of HER2-positive breast cancer is the overexpression of HER2, which sustains the generation of signals promoting cell survival and proliferation through self-dimerization and the activation of downstream pathways, including PI3K-AKT-mTOR and RAS-RAF cascades [5]. The gene discussed is ERBB2; the disease is breast carcinoma.